Displaying 65 (all) recruiting clinical trials.
-
A Phase 1b Open-Label Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
This is a Phase 1b study testing a combination of two medicines, cemsidomide and elranatamab, in patients with relapsed or hard-to-treat multiple myeloma (a type ...
Phase
Interventional
-
A Phase 1 First-in-human Dose Escalation Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
This is an early-stage (Phase 1) study testing a new drug called JNJ-95804306 (an experimental cancer drug) in people with certain blood cancers, including acute ...
Phase
Interventional
-
A Phase 1a/1b Open-Label Study Evaluating the Safety Tolerability Pharmacokinetics and Efficacy of BBO-11818 in Subjects with Advanced KRAS Mutant Cancers
This is a Phase 1 study testing whether the study medicine BBO-11818 (a pan-KRAS inhibitor) is safe and effective in patients with locally advanced solid ...
Phase
Interventional
-
A Phase 1b Open-label Study of CLN-978 for the Treatment of Active Moderate to Severe Sjogren s Disease
The purpose of this study is to investigate the safety, tolerability, and effectivness of an investigational drug called CLN-978 in patients with active Sjogren’s ...Phase
Interventional
-
A Phase 1 Trial of JNJ-98768111 an Antibody Drug Conjugate (ADC) Targeting Human Kallikrein-2 (KLK2) for Advanced Prostate Cancer
This Phase 1 study is testing a new drug called JNJ-98768111 in people with metastatic prostate cancer, meaning prostate cancer that has spread to other ...
Phase
Interventional
